Firing Line: Albert Bourla

United States
Written By Modern Treatise

CEO Albert Bourla discusses Pfizer’s eight-month race to develop a COVID-19 vaccine, which he thinks will be available to frontline workers in December and the general public before the summer. He talks about efficacy, safety and distribution.

Modern Treatise
Previous

Debate: It's Time For The West To Get Tough With China
Next

Latin Analysis: The Mexican-Brazilian Rivalry and Its Implications for Environmental Leadership